Escalon Medical Completes $3M AXIS Platform Sale, Receives $1M Initial Payment

summarizeSummary

Escalon Medical Corp. completed the sale of its AXIS platform software assets to Optos Public Limited Company for an aggregate purchase price of $3 million, receiving an initial $1 million milestone payment.

check_boxKey Events

• Asset Disposition Completed

  Escalon Medical Corp. completed the sale of its AXIS platform software assets to Optos Public Limited Company on January 23, 2026, as per an Asset Purchase Agreement dated October 22, 2025.

• Significant Cash Inflow

  The company received an initial milestone payment of $1,000,000 upon completion of the disposition, providing a substantial boost to its financial position.

• Future Milestone Payments

  The total aggregate purchase price is $3,000,000, with an additional $1,975,000 to be received in future milestone installments, contingent on specific conditions.

• Retained Licensing Rights

  Escalon retains a fully paid-up interim non-exclusive license for its existing PACS business for up to 12 months and a perpetual license for its ultrasound technology, ensuring continuity for these operations.

auto_awesomeAnalysis

Escalon Medical Corp. has completed the disposition of its AXIS platform software assets to Optos Public Limited Company for an aggregate purchase price of $3 million. This is a transformational event for a company of this size, as the total transaction value significantly exceeds its current market valuation. The immediate receipt of $1 million provides a substantial cash infusion, which is critical for a micro-cap company and can significantly improve its financial liquidity and operational runway. The company will receive additional milestone payments totaling $1.975 million, contingent on further conditions. While divesting a key asset, Escalon retains important licensing rights for its existing PACS and ultrasound businesses, mitigating immediate operational disruption. The transaction also includes a five-year non-compete clause in the PACS business.